Spironolactone, a therapeutic alternative in the treatment of diffuse retinal pigment epitheliopathy. [electronic resource]
- Archivos de la Sociedad Espanola de Oftalmologia Dec 2016
- 599-603 p. digital
Publication Type: Case Reports; Journal Article
1989-7286
10.1016/j.oftal.2016.02.007 doi
Humans Male Middle Aged Mineralocorticoid Receptor Antagonists--therapeutic use Retinal Detachment--drug therapy Spironolactone--therapeutic use